SensoLyte® 490 HIV Protease Assay Kit Fluorimetric - 1 kit
- Cat.Number : AS-71127
- Manufacturer Ref. :
-
Availability :
In stock
- Shipping conditions : Ice fees will apply
Alternative choices
HIV protease (PR) is identified as an important drug-screening target for the design of selective acquired immunodeficiency syndrome (AIDS) therapeutics. The SensoLyte® 490 HIV Protease Assay Kit uses an optimized FRET peptide substrate for a continuous measurement of HIV protease activities. This FRET-based fluorogenic substrate is derived from a natural processing site for HIV-1 PR. Incubation of the recombinant HIV-1 PR with this substrate results in specific cleavage and a time-dependent increase in fluorescence intensity that is linearly related to the extent of substrate hydrolysis. Because of its simplicity and precision in the determination of reaction rates required for kinetic analysis, this kit offers many advantages over the commonly used HPLC or electrophoresis-based assays for peptide substrate hydrolysis by retroviral PRs.
Specifications
Packaging | |
Kits components |
|
---|---|
Properties | |
Absorbance (nm) |
|
Emission (nm) |
|
Storage & stability | |
Storage Conditions |
|
Activity | |
Application | |
Biomarker Target | |
Detection Method | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Downloads
You may also be interested in the following product(s)
Citations
HIV protease: Multiple fold inhibition by silver nanoparticles—Spectrofluorimetric, thermodynamic and kinetic analysis
J Taiwan Inst Chem Engin . 2014 Jul 01 ; 45(4) 1140 | DOI : https://doi.org/10.1016/j.jtice.2014.01.008
- C.Y. Shing
Selective and facile assay of human immunodeficiency virus protease activity by a novel fluorogenic reaction
Anal Biochem . 2010 Feb 15 ; 397(2) 197 | DOI : 10.1016/j.ab.2009.10.030
- Z. Yu
Increased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activity
Vaccine . 2010 Nov 23 ; 29(4) 839 | DOI : 10.1016/j.vaccine.2010.10.083
- D. Hallengärd
A method to simultaneously monitor hepatitis C virus NS3 helicase and protease activities.
Methods Mol Biol . 2010 Jan 01 ; 587 223 | DOI : 10.1007/978-1-60327-355-8_16
- D.N. Frick
HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells
Cancers . 2023 Jan 01 ; 15(1) 238 | DOI : https://doi.org/10.3390/cancers15010238
- S. Petkov
- et al